Skip to content

Clinical trials

Phase 2/3 trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2/3 Country / region: Australia Clear all

318 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20024
20031
200416
200510
20069
20078
200810
20095
20107
20116
201210
20139
20148
201514
20168
201712
201812
201911
202016
202120
202227
202321
202426
202525
202618

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed137
Recruiting64
Terminated52
Active, not recruiting37
Unknown status12
Enrolling by invitation7
Not yet recruiting7
Suspended1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb14
Pfizer10
Janssen Research & Development, LLC9
AstraZeneca8
Hoffmann-La Roche7
Novartis Pharmaceuticals7
AbbVie6
Boehringer Ingelheim6
Sanofi6
Washington University School of Medicine6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease16
Neoplasms13
Carcinoma, Non-Small-Cell Lung11
Colitis, Ulcerative10
Dementia10
Neoplasm Metastasis9
Lymphoma8
Leukemia7
COVID-196
Heart Failure6

Trials

Showing 1 to 25 of 318. Each trial links to its page on Pharma Observatory.

218 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.